PURETECH HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 214 GBX | -0.93% |
|
+0.47% | +10.20% |
| 04-25 | Transcript : PureTech Health plc, 2023 Earnings Call, Apr 25, 2024 | |
| 04-25 | PureTech touts "momentum" as grants shrivel but annual loss narrows | AN |
Chart calendar PureTech Health plc
9d189dfcaa6f2d74208c3369.N-U-pVMFFzyu_Kfi1CeSewC6NHmSXeieMPnuy-8RILU.ZLAIwwRaVl-ZtMSpnh7lIU7WYBrzCdzYQrTfm5dFR-xQqXzEHlJfXdmO4g~f2605368f36018613cea894f05eecc83
Upcoming events on PureTech Health plc
Past events on PureTech Health plc
| 25/04/2024 14:00 | Q4 2023 Earnings Call |
| 25/04/2024 07:00 | Q4 2023 Earnings Release |
| 13/03/2024 14:40 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 18:30 | TD Cowen Health Care Conference |
| 10/01/2024 17:00 | JPMorgan Healthcare Conference |
| 06/12/2023 | European Society for Medical Oncology Immuno Oncology Congress |
| 29/11/2023 19:10 | Evercore ISI HealthCONx Conference |
| 15/11/2023 08:00 | Jefferies London Healthcare Conference |
| 29/08/2023 14:00 | Q2 2023 Earnings Call |
| 29/08/2023 07:00 | Q2 2023 Earnings Release |
| 13/06/2023 16:00 | Annual General Meeting |
| 07/06/2023 18:30 | Jefferies Global Healthcare Conference |
| 28/04/2023 14:00 | Q4 2022 Earnings Call |
| 28/04/2023 07:00 | Q4 2022 Earnings Release |
| 14/03/2023 20:05 | Barclays Global Healthcare Conference |
| 15/02/2023 15:40 | SVB Securities Global Biopharma Conference |
| 10/01/2023 22:15 | JP Morgan Healthcare Conference |
| 11/12/2022 | American Society of Hematology Meeting |
| 30/11/2022 13:50 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 29/11/2022 18:30 | Piper Sandler Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,81 28,4 -65.47% | 11,8 17,0 -30.82% | 17,4 12,8 35.65% | 15,6 7,40 111.05% | 3,33 4,60 -27.61% | 58,9 |
|
EBITDA Million USD | Released Forecast Spread | -129 -113 -13.83% | -113 -104 -8.96% | -143 -120 -18.72% | -189 -166 -13.8% | -141 -188 24.86% | -190 |
|
EBIT Million USD | Released Forecast Spread | -135 -124 -9.37% | -120 -112 -7.09% | -150 -141 -6.24% | -198 -181 -9.29% | -146 -211 30.61% | -212 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 478 -91,5 623.05% | 19,0 59,1 -67.88% | -59,0 -145 59.32% | -92,8 -182 48.88% | -36,1 -211 82.89% | -213 |
|
Net income Million USD | Released Forecast Spread | 421 17,9 2252.76% | 5,99 94,3 -93.66% | -60,6 -146 58.53% | -50,4 -100 49.67% | -65,7 -160 58.93% | -145 |
|
EPS USD | Released Forecast Spread | 1,44 -0,29 599.77% | 0,02 0,08 -74.91% | -0,21 -0,48 55.96% | -0,18 -0,64 71.65% | -0,24 -0,74 67.35% | -0,74 |
| Announcement Date | 09/04/20 | 15/04/21 | 26/04/22 | 28/04/23 | 25/04/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,42 36,6 -85.19% | 6,84 | 4,92 8,70 -43.4% | 5,84 6,05 -3.54% | 11,6 6,62 74.5% | 7,03 7,52 -6.56% | 8,59 7,80 10.1% | 3,15 102 -96.92% | 0,18 6,00 -97% | 7,50 | 110 |
|
EBIT Million USD | Released Forecast Spread | -65,1 -23,7 -174.61% | -52,3 | -66,7 -57,3 -16.56% | -68,1 -67,6 -0.78% | -82,2 -73,4 -12.02% | -101 -78,7 -28.55% | -76,2 2,10 -3726.81% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 467 -23,0 2131.96% | 174 | -156 -40,2 -287.17% | -94,9 -67,8 -40.02% | 36,0 -74,0 148.63% | -56,0 -71,7 21.93% | -13,7 24,6 -155.87% | ||||
|
Net income Million USD | Released Forecast Spread | 393 -10,4 3876.94% | 124 | -118 -39,3 -200.44% | -75,4 -67,8 -11.2% | 14,8 -74,0 120.06% | -28,3 -72,0 60.61% | -22,0 9,70 -326.91% | -25,0 7,30 -442.52% | -40,7 -89,7 54.63% | -83,5 | 7,00 |
|
EPS USD | Released Forecast Spread | 0,42 | -0,40 -1,03 60.98% | -0,10 -0,20 50% | -0,09 0,10 -190% | |||||||
| Announcement Date | 09/04/20 | 27/08/20 | 15/04/21 | 24/08/21 | 26/04/22 | 25/08/22 | 28/04/23 | 29/08/23 | 25/04/24 | - | - |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Past sector events for PureTech Health plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRTC Stock
- Calendar PureTech Health plc
